{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:53:45Z","timestamp":1773269625583,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770837"],"award-info":[{"award-number":["31770837"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research Project of Shandong Province","award":["2016GSF201217"],"award-info":[{"award-number":["2016GSF201217"]}]},{"name":"Qingdao, Shinan District Science and Technology Development Project Fund","award":["2016-3-016-YY"],"award-info":[{"award-number":["2016-3-016-YY"]}]},{"name":"Qingdao People\u2019s Livelihood Science and technology plan","award":["18-6-1-68-nsh"],"award-info":[{"award-number":["18-6-1-68-nsh"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biochem"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12858-019-0106-3","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T05:04:11Z","timestamp":1549429451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population"],"prefix":"10.1186","volume":"20","author":[{"given":"Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shousheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhui","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-7655","authenticated-orcid":false,"given":"Yongning","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiying","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"issue":"8","key":"106_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 2016;65(8):1109\u201323.","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"106_CR2","first-page":"S5","volume":"40","author":"JM Clark","year":"2006","unstructured":"Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl 1):S5\u201310.","journal-title":"J Clin Gastroenterol"},{"issue":"26","key":"106_CR3","first-page":"447","volume":"111","author":"J Weiss","year":"2014","unstructured":"Weiss J, Rau M, Geier A. Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int. 2014;111(26):447\u201352.","journal-title":"Dtsch Arztebl Int"},{"issue":"13","key":"106_CR4","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.3748\/wjg.v22.i13.3663","volume":"22","author":"ZY Lu","year":"2016","unstructured":"Lu ZY, Shao Z, Li YL, Wulasihan M, Chen XH. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. World J Gastroenterol. 2016;22(13):3663\u20139.","journal-title":"World J Gastroenterol"},{"key":"106_CR5","first-page":"140","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Liu Z, Wang K, Wang Z, Sun X, Zhong L, Deng G, Song G, Sun B, Peng Z, et al. Additive effects of the risk alleles of PNPLA3 and TM6SF2 on non-alcoholic fatty liver disease (NAFLD) in a Chinese population. Front Genet. 2016;7:140.","journal-title":"Front Genet"},{"key":"106_CR6","doi-asserted-by":"publisher","first-page":"9284","DOI":"10.1038\/srep09284","volume":"5","author":"R Xu","year":"2015","unstructured":"Xu R, Tao A, Zhang S, Deng Y, Chen G. Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis. Sci Rep. 2015;5:9284.","journal-title":"Sci Rep"},{"issue":"4","key":"106_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/hep.24793","volume":"55","author":"LP Bechmann","year":"2012","unstructured":"Bechmann LP, Gastaldelli A, Vetter D, Patman GL, Pascoe L, Hannivoort RA, Lee UE, Fiel I, Munoz U, Ciociaro D, et al. Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology. 2012;55(4):1083\u201393.","journal-title":"Hepatology"},{"issue":"6","key":"106_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s00535-013-0850-x","volume":"49","author":"HL Tan","year":"2014","unstructured":"Tan HL, Zain SM, Mohamed R, Rampal S, Chin KF, Basu RC, Cheah PL, Mahadeva S, Mohamed Z. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene. J Gastroenterol. 2014;49(6):1056\u201364.","journal-title":"J Gastroenterol"},{"issue":"12","key":"106_CR9","doi-asserted-by":"publisher","first-page":"e33155","DOI":"10.5812\/hepatmon.33155","volume":"15","author":"C Yuan","year":"2015","unstructured":"Yuan C, Lu L, An B, Jin W, Dong Q, Xin Y, Xuan S. Association between LYPLAL1 rs12137855 polymorphism with ultrasound-defined non-alcoholic fatty liver disease in a Chinese Han population. Hepat Mon. 2015;15(12):e33155.","journal-title":"Hepat Mon"},{"issue":"2","key":"106_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.yexmp.2015.01.012","volume":"98","author":"P Leon-Mimila","year":"2015","unstructured":"Leon-Mimila P, Vega-Badillo J, Gutierrez-Vidal R, Villamil-Ramirez H, Villareal-Molina T, Larrieta-Carrasco E, Lopez-Contreras BE, Kauffer LR, Maldonado-Pintado DG, Mendez-Sanchez N, et al. A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity. Exp Mol Pathol. 2015;98(2):178\u201383.","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"106_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybjaerg-Hansen A, Vogt TF, Hobbs HH, Cohen JC. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46(4):352\u20136.","journal-title":"Nat Genet"},{"issue":"4","key":"106_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.14218\/JCTH.2015.00023","volume":"3","author":"LZ Chen","year":"2015","unstructured":"Chen LZ, Xia HH, Xin YN, Lin ZH, Xuan SY. TM6SF2 E167K variant, a novel genetic susceptibility variant, contributing to nonalcoholic fatty liver disease. J Clin Transl Hepatol. 2015;3(4):265\u201370.","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"106_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1194\/jlr.M075028","volume":"58","author":"G Musso","year":"2017","unstructured":"Musso G, Cipolla U, Cassader M, Pinach S, Saba F, De Michieli F, Paschetta E, Bongiovanni D, Framarin L, Leone N, et al. TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD. J Lipid Res. 2017;58(6):1221\u20139.","journal-title":"J Lipid Res"},{"issue":"2","key":"106_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ijpo.12032","volume":"11","author":"A Grandone","year":"2016","unstructured":"Grandone A, Cozzolino D, Marzuillo P, Cirillo G, Di Sessa A, Ruggiero L, Di Palma MR, Perrone L, Miraglia Del Giudice E. TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children. Pediatr Obes. 2016;11(2):115\u20139.","journal-title":"Pediatr Obes"},{"issue":"6","key":"106_CR15","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jhep.2015.01.040","volume":"62","author":"X Wang","year":"2015","unstructured":"Wang X, Liu Z, Peng Z, Liu W. The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese. J Hepatol. 2015;62(6):1438\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"106_CR16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jhep.2014.04.047","volume":"61","author":"VW Wong","year":"2014","unstructured":"Wong VW, Wong GL, Tse CH, Chan HL. Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese. J Hepatol. 2014;61(3):708\u20139.","journal-title":"J Hepatol"},{"issue":"4","key":"106_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"2","key":"106_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.15403\/jgld.2014.1121.232.dsw1","volume":"23","author":"D Sawbridge","year":"2014","unstructured":"Sawbridge D, Probert C. Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers review. J Gastrointestin Liver Dis. 2014;23(2):195\u2013202.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"8","key":"106_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa1100370","volume":"366","author":"AG Zauber","year":"2012","unstructured":"Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687\u201396.","journal-title":"N Engl J Med"},{"issue":"7","key":"106_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cgh.2012.12.004","volume":"11","author":"S Sweetser","year":"2013","unstructured":"Sweetser S, Smyrk TC, Sinicrope FA. Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol. 2013;11(7):760\u20137 quiz e754\u2013765.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"106_CR21","first-page":"322","volume":"8","author":"W Ding","year":"2015","unstructured":"Ding W, Fan J, Qin J. Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(1):322\u201333.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"106_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1440-1746.2009.06117.x","volume":"25","author":"ST Hwang","year":"2010","unstructured":"Hwang ST, Cho YK, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Won KH, Jin W. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol. 2010;25(3):562\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"106_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1440-1746.2011.06816.x","volume":"27","author":"YI Lee","year":"2012","unstructured":"Lee YI, Lim YS, Park HS. Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. J Gastroenterol Hepatol. 2012;27(1):91\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"28","key":"106_CR24","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.3748\/wjg.v23.i28.5206","volume":"23","author":"QF Chen","year":"2017","unstructured":"Chen QF, Zhou XD, Sun YJ, Fang DH, Zhao Q, Huang JH, Jin Y, Wu JS. Sex-influenced association of non-alcoholic fatty liver disease with colorectal adenomatous and hyperplastic polyps. World J Gastroenterol. 2017;23(28):5206\u201315.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"106_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/01635581.2011.542539","volume":"63","author":"RL Galbraith","year":"2011","unstructured":"Galbraith RL, Poole EM, Duggan D, Muehling J, Hsu L, Makar K, Xiao L, Potter JD, Ulrich CM. Polymorphisms in WNT6 and WNT10A and colorectal adenoma risk. Nutr Cancer. 2011;63(4):558\u201364.","journal-title":"Nutr Cancer"},{"issue":"1","key":"106_CR26","first-page":"297","volume":"12","author":"G Yin","year":"2011","unstructured":"Yin G, Hamajima N, Morita M, Tajima O, Tabata S, Kono S. Lack of influence of the ADH1B Arg47His genetic polymorphism on risk of colorectal adenoma in middle-aged Japanese men. Asian Pac J Cancer Prev. 2011;12(1):297\u2013302.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"106_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/carcin\/bgs158","volume":"33","author":"AM Gilsing","year":"2012","unstructured":"Gilsing AM, Berndt SI, Ruder EH, Graubard BI, Ferrucci LM, Burdett L, Weissfeld JL, Cross AJ, Sinha R. Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis. 2012;33(7):1332\u20139.","journal-title":"Carcinogenesis"},{"issue":"5402","key":"106_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmj.2.5402.177","volume":"2","author":"PP Rickham","year":"1964","unstructured":"Rickham PP. Human Experimentation. Code of ethics of the world medical association. Declaration Of Helsinki. Br Med J. 1964;2(5402):177.","journal-title":"Br Med J"},{"issue":"1","key":"106_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","volume":"12","author":"JG Fan","year":"2011","unstructured":"Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, Chan LY. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese journal of hepatology 2010; 18:163-166). J Dig Dis. 2011;12(1):38\u201344.","journal-title":"J Dig Dis"},{"issue":"4","key":"106_CR30","doi-asserted-by":"publisher","first-page":"e35055","DOI":"10.5812\/hepatmon.35055","volume":"16","author":"BQ An","year":"2016","unstructured":"An BQ, Lu LL, Yuan C, Xin YN, Xuan SY. Leptin receptor gene polymorphisms and the risk of non-alcoholic fatty liver disease and coronary atherosclerosis in the Chinese Han population. Hepat Mon. 2016;16(4):e35055.","journal-title":"Hepat Mon"},{"issue":"8","key":"106_CR31","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","volume":"65","author":"M Mota","year":"2016","unstructured":"Mota M, Banini BA, Cazanave SC, Sanyal AJ. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1049\u201361.","journal-title":"Metabolism"},{"issue":"11","key":"106_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Day CP. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10(11):645\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"106_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrgastro.2014.232","volume":"12","author":"ME Rinella","year":"2015","unstructured":"Rinella ME, Sanyal AJ. NAFLD in 2014: genetics, diagnostics and therapeutic advances in NAFLD. Nat Rev Gastroenterol Hepatol. 2015;12(2):65\u20136.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 6","key":"106_CR34","doi-asserted-by":"publisher","first-page":"s77","DOI":"10.7861\/clinmedicine.15-6-s77","volume":"15","author":"RJ Rowell","year":"2015","unstructured":"Rowell RJ, Anstee QM. An overview of the genetics, mechanisms and management of NAFLD and ALD. Clin Med (Lond). 2015;15(Suppl 6):s77\u201382.","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"106_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0035-1562947","volume":"35","author":"QM Anstee","year":"2015","unstructured":"Anstee QM, Day CP. The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2. Semin Liver Dis. 2015;35(3):270\u201390.","journal-title":"Semin Liver Dis"},{"key":"106_CR36","doi-asserted-by":"crossref","unstructured":"Sanna C, Rosso C, Marietti M, Bugianesi E. Non-alcoholic fatty liver disease and extra-hepatic cancers. Int J Mol Sci. 2016;17(5).","DOI":"10.3390\/ijms17050717"},{"issue":"7","key":"106_CR37","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/jgh.13684","volume":"32","author":"CM Moon","year":"2017","unstructured":"Moon CM, Yun KE, Ryu S, Chang Y, Park DI. High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men. J Gastroenterol Hepatol. 2017;32(7):1310\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"106_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","volume":"28","author":"P Dietrich","year":"2014","unstructured":"Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014;28(4):637\u201353.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"32","key":"106_CR39","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","volume":"22","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan((R))) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - where do we stand? World J Gastroenterol. 2016;22(32):7236\u201351.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"106_CR40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","volume":"10","author":"L Castera","year":"2013","unstructured":"Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10(11):666\u201375.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"106_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jhep.2014.10.010","volume":"62","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Llaurado G, Oresic M, Hyotylainen T, Orho-Melander M, Yki-Jarvinen H. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2. J Hepatol. 2015;62(3):657\u201363.","journal-title":"J Hepatol"},{"issue":"2","key":"106_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hep.27556","volume":"61","author":"S Sookoian","year":"2015","unstructured":"Sookoian S, Castano GO, Scian R, Mallardi P, Fernandez Gianotti T, Burgueno AL, San Martino J, Pirola CJ. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology. 2015;61(2):515\u201325.","journal-title":"Hepatology"},{"key":"106_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mam.2016.11.008","volume":"54","author":"J Lee","year":"2017","unstructured":"Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Asp Med. 2017;54:78\u201388.","journal-title":"Mol Asp Med"},{"issue":"12","key":"106_CR44","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/hmg\/ddy124","volume":"27","author":"E Sliz","year":"2018","unstructured":"Sliz E, Sebert S, Wurtz P, Kangas AJ, Soininen P, Lehtimaki T, Kahonen M, Viikari J, Mannikko M, Ala-Korpela M, et al. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Hum Mol Genet. 2018;27(12):2214\u201323.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"106_CR45","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/hep.29021","volume":"65","author":"EA O'Hare","year":"2017","unstructured":"O'Hare EA, Yang R, Yerges-Armstrong LM, Sreenivasan U, McFarland R, Leitch CC, Wilson MH, Narina S, Gorden A, Ryan KA, et al. TM6SF2 rs58542926 impacts lipid processing in liver and small intestine. Hepatology. 2017;65(5):1526\u201342.","journal-title":"Hepatology"},{"key":"106_CR46","first-page":"817","volume":"15","author":"MR McGill","year":"2016","unstructured":"McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 2016;15:817\u201328.","journal-title":"EXCLI J"}],"container-title":["BMC Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12858-019-0106-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12858-019-0106-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12858-019-0106-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T19:13:58Z","timestamp":1580930038000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiochem.biomedcentral.com\/articles\/10.1186\/s12858-019-0106-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1186\/s12858-019-0106-3","relation":{},"ISSN":["1471-2091"],"issn-type":[{"value":"1471-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"24 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Qingdao municipal hospital (approval No: 2016\u4e34\u5ba1\u5b57\u7b2c17\u53f7). All patients and healthy persons included in this study provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients and healthy persons included in this study provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"3"}}